BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12535382)

  • 1. Differential gene expression in human cerebrovascular malformations.
    Shenkar R; Elliott JP; Diener K; Gault J; Hu LJ; Cohrs RJ; Phang T; Hunter L; Breeze RE; Awad IA
    Neurosurgery; 2003 Feb; 52(2):465-77; discussion 477-8. PubMed ID: 12535382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations.
    Uranishi R; Awadallah NA; Ogunshola OO; Awad IA
    Neurosurgery; 2002 Jan; 50(1):110-5; discussion 115-6. PubMed ID: 11844241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
    Uranishi R; Baev NI; Ng PY; Kim JH; Awad IA
    Neurosurgery; 2001 Feb; 48(2):359-67; discussion 367-8. PubMed ID: 11220380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies.
    Kiliç T; Pamir MN; Küllü S; Eren F; Ozek MM; Black PM
    Neurosurgery; 2000 May; 46(5):1179-91; discussion 1191-2. PubMed ID: 10807251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of integrins in cerebral arteriovenous and cavernous malformations.
    Seker A; Yildirim O; Kurtkaya O; Sav A; Günel M; Pamir MN; Kiliç T
    Neurosurgery; 2006 Jan; 58(1):159-68; discussion 159-68. PubMed ID: 16385340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cell differentiation in human cerebral vascular malformations.
    Uranishi R; Baev NI; Kim JH; Awad IA
    Neurosurgery; 2001 Sep; 49(3):671-9; discussion 679-80. PubMed ID: 11523679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanistic overlap between cavernous malformations and cerebral developmental venous anomalies.
    Sughrue ME; Connolly ES
    Stroke; 2005 Nov; 36(11):2339. PubMed ID: 16239627
    [No Abstract]   [Full Text] [Related]  

  • 8. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations.
    Shenkar R; Shi C; Check IJ; Lipton HL; Awad IA
    Neurosurgery; 2007 Oct; 61(4):693-702; discussion 702-3. PubMed ID: 17986930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific repression of the preproendothelin-1 gene in intracranial arteriovenous malformations.
    Rhoten RL; Comair YG; Shedid D; Chyatte D; Simonson MS
    J Neurosurg; 1997 Jan; 86(1):101-8. PubMed ID: 8988087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial cerebral cavernous angioma: clinical analysis of a family and phenotypic classification.
    Gil-Nagel A; Wilcox KJ; Stewart JM; Anderson VE; Leppik IE; Rich SS
    Epilepsy Res; 1995 May; 21(1):27-36. PubMed ID: 7641673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
    Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial occurrence of multiple vascular malformations of the brain].
    Takamiya Y; Takayama H; Kobayashi K; Mine T; Suzuki K
    Neurol Med Chir (Tokyo); 1984 Apr; 24(4):271-7. PubMed ID: 6205313
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
    Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
    Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression in relation to the clinical characteristics of human brain arteriovenous malformations.
    Takagi Y; Aoki T; Takahashi JC; Yoshida K; Ishii A; Arakawa Y; Kikuchi T; Funaki T; Miyamoto S
    Neurol Med Chir (Tokyo); 2014; 54(3):163-75. PubMed ID: 24162243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.
    Wong JH; Awad IA; Kim JH
    Neurosurgery; 2000 Jun; 46(6):1454-9. PubMed ID: 10834648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations.
    Rothbart D; Awad IA; Lee J; Kim J; Harbaugh R; Criscuolo GR
    Neurosurgery; 1996 May; 38(5):915-24; discussion 924-5. PubMed ID: 8727816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and blood flow MR findings in cerebral vascular malformations.
    Biondi A; Scialfa G
    J Neuroradiol; 1988; 15(3):253-65. PubMed ID: 3246602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed vascular malformations of the brain: clinical and pathogenetic considerations.
    Awad IA; Robinson JR; Mohanty S; Estes ML
    Neurosurgery; 1993 Aug; 33(2):179-88; discussion 188. PubMed ID: 8367039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation.
    Shi C; Shenkar R; Batjer HH; Check IJ; Awad IA
    J Neurosurg; 2007 Nov; 107(5):1023-6. PubMed ID: 17977276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary neurocutaneous angiomatosis. Report of four cases.
    Leblanc R; Melanson D; Wilkinson RD
    J Neurosurg; 1996 Dec; 85(6):1135-42. PubMed ID: 8929507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.